U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07083115) titled 'Developing MRI Technologies for Atrial Fibrillation' on July 16.
Brief Summary: To measure image quality of damaged areas of the heart in patients with Atrial fibrillation using the contrast Gadopiclenol vs conventional Gadolinium-based contrast agents(GBCA)
Study Start Date: Sept., 2025
Study Type: OBSERVATIONAL
Condition:
Atrial Fibrillation (AF)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: The Cleveland Clinic
Information provided by (Responsible Party): Christopher Nguyen, The Cleveland Clinic
Published by HT Digital Content Services with permission from Health Daily Digest....